• All
  • Capitol Securities News
  • Equity Research
  • Independent Office
  • Locations
  • Market Commentary

The proverbial “stay at home trade” is thriving even following encouraging news on a potential virus vaccine. There are now over 130 vaccines in the development process and 17 are in late stage testing with some ...